Advancing New Cancer Treatments Through a Collaborative Network
NCI ETCTN Pittsburgh Cancer Consortium (PCC)
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11078342
This program brings together leading cancer centers to find and test promising new cancer drugs for adult patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11078342 on ClinicalTrials.gov |
What this research studies
This program connects several major cancer centers, including the University of Pittsburgh, the University of Florida, and the Albert Einstein Cancer Center, to work together. Our goal is to speed up the process of finding and testing new medicines for cancer. We focus on early-stage clinical trials, which are often the first time a new drug is given to people, to see if it is safe and effective for adult cancer patients. This collaborative network aims to streamline the advancement of novel experimental therapies.
Who could benefit from this research
Good fit: Ideal candidates are adult cancer patients who may be eligible for early-phase clinical trials testing new experimental therapies.
Not a fit: Patients who do not meet the specific eligibility criteria for the early-phase clinical trials conducted through this network may not directly benefit from participation.
Why it matters
Potential benefit: If successful, this collaborative effort could lead to the discovery and faster availability of new, life-saving treatments for various cancers.
How similar studies have performed: The National Cancer Institute has a long history of supporting clinical trial networks, and this program builds upon decades of experience in developing new cancer therapies.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VILLARUZ, LIZA COSCA — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: VILLARUZ, LIZA COSCA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Albert Einstein Cancer Center, Anti-Cancer Agents, Cancer Center, Cancer Drug, Cancer Patient